相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Anti-PEG antibodies compromise the integrity of PEGylated lipid-based nanoparticles via complement
Mariona Estape Senti et al.
JOURNAL OF CONTROLLED RELEASE (2022)
Branched PEG-modification: A new strategy for nanocarriers to evade of the accelerated blood clearance phenomenon and enhance anti-tumor efficacy
Min Liu et al.
BIOMATERIALS (2022)
A preliminary study of the innate immune memory of Kupffer cells induced by PEGylated nanoemulsions
Mengyang Liu et al.
JOURNAL OF CONTROLLED RELEASE (2022)
Chemical and Biophysical Signatures of the Protein Corona in Nanomedicine
Jiayu Ren et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2022)
Engineering a folic acid-decorated ultrasmall gemcitabine nanocarrier for breast cancer therapy: Dual targeting of tumor cells and tumor-associated macrophages
Pearl Moharil et al.
ACTA PHARMACEUTICA SINICA B (2022)
Folic Acid Enables Targeting Delivery of Lipodiscs by Circumventing IgM-Mediated Opsonization
Huan Wang et al.
NANO LETTERS (2022)
Morphology-driven protein corona manipulation for preferential delivery of lipid nanodiscs
Tao Chen et al.
NANO TODAY (2022)
Cryo-EM structure of the human IgM B cell receptor
Qiang Su et al.
SCIENCE (2022)
Cryo-EM structures of two human B cell receptor isotypes
Xinyu Ma et al.
SCIENCE (2022)
Pre-treatment with high molecular weight free PEG effectively suppresses anti-PEG antibody induction by PEG-liposomes in mice
Morgan D. McSweeney et al.
JOURNAL OF CONTROLLED RELEASE (2021)
Engineering precision nanoparticles for drug delivery
Michael J. Mitchell et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
Allergenic components of the mRNA-1273 vaccine for COVID-19: Possible involvement of polyethylene glycol and IgG-mediated complement activation
Ludger Klimek et al.
ALLERGY (2021)
Unraveling the Effect of Breast Cancer Patients' Plasma on the Targeting Ability of Folic Acid-Modified Chitosan Nanoparticles
Mahdieh Nemati et al.
MOLECULAR PHARMACEUTICS (2021)
Facile Separation of PEGylated Liposomes Enabled by Anti-PEG scFv
Wenjing Tang et al.
NANO LETTERS (2021)
Anti-PEG scFv corona ameliorates accelerated blood clearance phenomenon of PEGylated nanomedicines
Zui Zhang et al.
JOURNAL OF CONTROLLED RELEASE (2021)
Allergic Reactions and Anaphylaxis to LNP-Based COVID-19 Vaccines
S. Moein Moghimi
MOLECULAR THERAPY (2021)
Deciphering Protein Corona by scFv-Based Affinity Chromatography
Yuxiu Chu et al.
NANO LETTERS (2021)
Self-Adjuvant Effect by Manipulating the Bionano Interface of Liposome-Based Nanovaccines
Zhuxuan Jiang et al.
NANO LETTERS (2021)
Delivery strategies of amphotericin B for invasive fungal infections
Xiaochun Wang et al.
ACTA PHARMACEUTICA SINICA B (2021)
Liposome composition in drug delivery design, synthesis, characterization, and clinical application
Danielle E. Large et al.
ADVANCED DRUG DELIVERY REVIEWS (2021)
Immunosuppressive drugs modes of action
Maria Meneghini et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2021)
Stimulus-responsive liposomes for biomedical applications
Antonia Antoniou et al.
DRUG DISCOVERY TODAY (2021)
Interrogating preclinical study of liposomes: The effect of mouse strain reexamined
Juan Guan et al.
JOURNAL OF CONTROLLED RELEASE (2021)
Generation of Novel Human Red Blood Cell-Bearing Humanized Mouse Models Based on C3-Deficient NOG Mice
Takuya Yamaguchi et al.
FRONTIERS IN IMMUNOLOGY (2021)
Natural IgM dominates in vivo performance of liposomes
Tianhao Ding et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Structural insights into immunoglobulin M
Yaxin Li et al.
SCIENCE (2020)
Impact of the protein corona on nanomaterial immune response and targeting ability
Luca Digiacomo et al.
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY (2020)
Premature Drug Release from Polyethylene Glycol (PEG)-Coated Liposomal Doxorubicin via Formation of the Membrane Attack Complex
Even Chen et al.
ACS NANO (2020)
Anti-PEG antibodies: Properties, formation, testing and role in adverse immune reactions to PEGylated nano-biopharmaceuticals
Gergely Tibor Kozma et al.
ADVANCED DRUG DELIVERY REVIEWS (2020)
Enhancement of the blood-circulation time and performance of nanomedicines via the forced clearance of erythrocytes
Maxim P. Nikitin et al.
NATURE BIOMEDICAL ENGINEERING (2020)
The influx/efflux mechanisms of D-peptide ligand of nAChRs across the blood-brain barrier and its therapeutic value in treating glioma
Bing Han et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Interrogation of Folic Acid-Functionalized Nanomedicines: The Regulatory Roles of Plasma Proteins Reexamined
Huan Wang et al.
ACS NANO (2020)
Structure, Function, and Therapeutic Use of IgM Antibodies
Bruce A. Keyt et al.
ANTIBODIES (2020)
Folate receptors and transporters: biological role and diagnostic/therapeutic targets in cancer and other diseases
Barbara Frigerio et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Pseudo-anaphylaxis to Polyethylene Glycol (PEG)-Coated Liposomes: Roles of Anti-PEG IgM and Complement Activation in a Porcine Model of Human Infusion Reactions
Gergely Tibor Kozma et al.
ACS NANO (2019)
Functionalization of Liposomes with Hydrophilic Polymers Results in Macrophage Uptake Independent of the Protein Corona
Claudia Weber et al.
BIOMACROMOLECULES (2019)
Secreted IgM: New tricks for an old molecule
Rebecca Blandino et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2019)
Insights into IgM-mediated complement activation based on in situ structures of IgM-C1-C4b
Thomas H. Sharp et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
PEGylated liposomes: immunological responses
Marwa Mohamed et al.
SCIENCE AND TECHNOLOGY OF ADVANCED MATERIALS (2019)
Rituximab-associated Hypogammaglobulinemia in pediatric patients with autoimmune diseases
Amer M. Khojah et al.
PEDIATRIC RHEUMATOLOGY (2019)
A generic method for the detection of polyethylene glycol specific IgG and IgM antibodies in human serum
Christopher Ehlinger et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2019)
Effect of Kupffer cells depletion on ABC phenomenon induced by Kupffer cells-targeted liposomes
Chaoyang Lai et al.
ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2019)
Brain-targeted drug delivery by manipulating protein corona functions
Zui Zhang et al.
NATURE COMMUNICATIONS (2019)
Interplay of protein corona and immune cells controls blood residency of liposomes
Francesca Giulimondi et al.
NATURE COMMUNICATIONS (2019)
The Human In Vivo Biomolecule Corona onto PEGylated Liposomes: A Proof-of-Concept Clinical Study
Marilena Hadjidemetriou et al.
ADVANCED MATERIALS (2019)
FDA Approval Summary: (Daunorubicin and Cytarabine) Liposome for Injection for the Treatment of Adults with High-Risk Acute Myeloid Leukemia
Aviva C. Krauss et al.
CLINICAL CANCER RESEARCH (2019)
The hyper IgM syndromes: Epidemiology, pathogenesis, clinical manifestations, diagnosis and management
Reza Yazdani et al.
CLINICAL IMMUNOLOGY (2019)
Immunoglobulin deposition on biomolecule corona determines complement opsonization efficiency of preclinical and clinical nanoparticles
Vivian P. Vu et al.
NATURE NANOTECHNOLOGY (2019)
Complement activation in vitro and reactogenicity of low-molecular weight dextran-coated SPIONs in the pig CARPA model: Correlation with physicochemical features and clinical information
Tamas Fulop et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Understanding the Role of Anti-PEG Antibodies in the Complement Activation by Doxil in Vitro
Barry W. Neun et al.
MOLECULES (2018)
Pre-adsorption of antibodies enables targeting of nanocarriers despite a biomolecular corona
Manuel Tonigold et al.
NATURE NANOTECHNOLOGY (2018)
Pre-existing anti-polyethylene glycol antibody reduces the therapeutic efficacy and pharmacokinetics of PEGylated liposomes
Yuan-Chin Hsieh et al.
THERANOSTICS (2018)
Evaluating the Accelerated Blood Clearance Phenomenon of PEGylated Nanoemulsions in Rats by Intraperitoneal Administration
Yuqing Su et al.
AAPS PHARMSCITECH (2018)
Tumor-shed antigen CA125 blocks complement-mediated killing via suppression of C1q-antibody binding
J. Bradford Kline et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2018)
Anti-polyethylene glycol antibodies alter the protein corona deposited on nanoparticles and the physiological pathways regulating their fate in vivo
Philippe Grenier et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Effects of Protein Corona on Active and Passive Targeting of Cyclic RGD Peptide-Functionalized PEGylation Nanoparticles
Gaoxing Su et al.
MOLECULAR PHARMACEUTICS (2018)
Enhanced immunocompatibility of ligand-targeted liposomes by attenuating natural IgM absorption
Juan Guan et al.
NATURE COMMUNICATIONS (2018)
Safety and pharmacokinetics of MM-302, a HER2-targeted antibody-liposomal doxorubicin conjugate, in patients with advanced HER2-positive breast cancer: a phase 1 dose-escalation study
Pamela Munster et al.
BRITISH JOURNAL OF CANCER (2018)
Protein bio-corona: critical issue in immune nanotoxicology
Monica Neagu et al.
ARCHIVES OF TOXICOLOGY (2017)
Complement proteins bind to nanoparticle protein corona and undergo dynamic exchange in vivo
Fangfang Chen et al.
NATURE NANOTECHNOLOGY (2017)
NANOMEDICINE Evolution of the nanoparticle corona
Marilena Hadjidemetriou et al.
NATURE NANOTECHNOLOGY (2017)
Molecular cell biology of complement membrane attack
B. Paul Morgan et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2017)
A genome-wide association study identifies a novel susceptibility locus for the immunogenicity of polyethylene glycol
Chia-Jung Chang et al.
NATURE COMMUNICATIONS (2017)
Cancer nanomedicine: progress, challenges and opportunities
Jinjun Shi et al.
NATURE REVIEWS CANCER (2017)
A Decade of the Protein Corona
Pu Chun Ke et al.
ACS NANO (2017)
Analysis of Pre-existing IgG and IgM Antibodies against Polyethylene Glycol (PEG) in the General Population
Qi Yang et al.
ANALYTICAL CHEMISTRY (2016)
Physical exercise modulates the homeostasis of human regulatory T cells
Max Weinhold et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
Anti-PEG antibodies in the clinic: Current issues and beyond PEGylation
Peng Zhang et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Time-evolution of in vivo protein corona onto blood-circulating PEGylated liposomal doxorubicin (DOXIL) nanoparticles
Marilena Hadjidemetriou et al.
NANOSCALE (2016)
Analysis of nanoparticle delivery to tumours
Stefan Wilhelm et al.
NATURE REVIEWS MATERIALS (2016)
In Vivo Biomolecule Corona around Blood-Circulating, Clinically Used and Antibody-Targeted Lipid Bilayer Nanoscale Vesicles
Marilena Hadjidemetriou et al.
ACS NANO (2015)
A D-Peptide Ligand of Nicotine Acetylcholine Receptors for Brain-Targeted Drug Delivery
Xiaoli Wei et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2015)
Relationship between the Concentration of Anti-polyethylene Glycol (PEG) Immunoglobulin M (IgM) and the Intensity of the Accelerated Blood Clearance (ABC) Phenomenon against PEGylated Liposomes in Mice
Yosuke Hashimoto et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2015)
The nanoparticle biomolecule corona: lessons learned - challenge accepted?
D. Docter et al.
CHEMICAL SOCIETY REVIEWS (2015)
Liposome-based glioma targeted drug delivery enabled by stable peptide ligands
Xiaoli Wei et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Anti-PEG immunity: emergence, characteristics, and unaddressed questions
Qi Yang et al.
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY (2015)
Glutathione pegylated liposomal methylprednisolone administration after the early phase of status epilepticus did not modify epileptogenesis in the rat
Linda Holtman et al.
EPILEPSY RESEARCH (2014)
Influence of dose and animal species on accelerated blood clearance of PEGylated liposomal doxorubicin
Takuya Suzuki et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2014)
Features of complement activation-related pseudoallergy to liposomes with different surface charge and PEGylation: Comparison of the porcine and rat responses
Laszlo Dezsi et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Enhanced Doxorubicin Delivery to the Brain Administered Through Glutathione PEGylated Liposomal Doxorubicin (2B3-101) as Compared with Generic Caelyx,®/Doxil®A Cerebral Open Flow Microperfusion Pilot Study
Thomas Birngruber et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2014)
Complement activation-related pseudoallergy: A stress reaction in blood triggered by nanomedicines and biologicals
Janos Szebeni
MOLECULAR IMMUNOLOGY (2014)
Generation, characterization and in vivo biological activity of two distinct monoclonal anti-PEG IgMs
Yosuke Hashimoto et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2014)
Induced and pre-existing anti-polyethylene glycol antibody in a trial of every 3-week dosing of pegloticase for refractory gout, including in organ transplant recipients
Michael S. Hershfield et al.
ARTHRITIS RESEARCH & THERAPY (2014)
Decreased reticuloendothelial system clearance and increased blood half-life and immune cell labeling for nano- and micron-sized superparamagnetic iron-oxide particles upon pre-treatment with Intralipid
Li Liu et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2013)
Use of polyglycerol (PG), instead of polyethylene glycol (PEG), prevents induction of the accelerated blood clearance phenomenon against long-circulating liposomes upon repeated administration
Amr S. Abu Lila et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2013)
Antibody Response Against Betaferon® in Immune Tolerant Mice: Involvement of Marginal Zone B-cells and CD4+T-cells and Apparent Lack of Immunological Memory
Melody Sauerborn et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2013)
Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface
Anna Salvati et al.
NATURE NANOTECHNOLOGY (2013)
Accelerated Blood Clearance of PEGylated PLGA Nanoparticles Following Repeated Injections: Effects of Polymer Dose, PEG Coating, and Encapsulated Anticancer Drug
Roonak Saadati et al.
PHARMACEUTICAL RESEARCH (2013)
Marginal zone B cells: virtues of innate-like antibody-producing lymphocytes
Andrea Cerutti et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Antibodies against polyethylene glycol in healthy subjects and in patients treated with PEG-conjugated agents
Ricardo P. Garay et al.
EXPERT OPINION ON DRUG DELIVERY (2012)
Doxil® - The first FDA-approved nano-drug: Lessons learned
Yechezkel (Chezy) Barenholz
JOURNAL OF CONTROLLED RELEASE (2012)
Endogenous antigen tunes the responsiveness of naive B cells but not T cells
Julie Zikherman et al.
NATURE (2012)
The dissociation activation model of B cell antigen receptor triggering
Jianying Yang et al.
FEBS LETTERS (2010)
Curvature of Synthetic and Natural Surfaces Is an Important Target Feature in Classical Pathway Complement Activation
Martin Bjerregard Pedersen et al.
JOURNAL OF IMMUNOLOGY (2010)
The importance of natural IgM: scavenger, protector and regulator
Michael R. Ehrenstein et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Phase III trial of gemcitabine compared with pegylated liposomal doxorubicin in progressive or recurrent ovarian cancer
Gabriella Ferrandina et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
The contribution of phagocytic activity of liver macrophages to the accelerated blood clearance (ABC) phenomenon of PEGylated liposomes in rats
Tatsuhiro Ishida et al.
JOURNAL OF CONTROLLED RELEASE (2008)
Safety and efficacy of additional courses of rituximab in patients with active rheumatoid arthritis
Edward Keystone et al.
ARTHRITIS AND RHEUMATISM (2007)
PEGylated liposomes elicit an anti-PEG IgM response in a T cell-independent manner
Tatsuhiro Ishida et al.
JOURNAL OF CONTROLLED RELEASE (2007)
Antibody against poly(ethylene glycol) adversely affects PEG-asparaginase therapy in acute lymphoblastic leukemia patients
Jonathan K. Armstrong et al.
CANCER (2007)
Spleen plays an important role in the induction of accelerated blood clearance of PEGylated liposomes
Tatsuhiro Ishida et al.
JOURNAL OF CONTROLLED RELEASE (2006)
Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models
Dmitri B. Kirpotin et al.
CANCER RESEARCH (2006)
Injection of PEGylated liposomes in rats elicits PEG-specific IgM, which is responsible for rapid elimination of a second dose of PEGylated liposomes
T Ishida et al.
JOURNAL OF CONTROLLED RELEASE (2006)
Antibodies neutralizing peginterferon alfa during retreatment of hepatitis C
AA van der Eijk et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Control of hyperuricemia in subjects with refractory gout, and induction of antibody against poly(ethylene glycol) (PEG), in a phase I trial of subcutaneous PEGylated urate oxidase
NJ Ganson et al.
ARTHRITIS RESEARCH & THERAPY (2006)
Preclinical manufacture of an anti-HER2 scFv-PEG-DSPE, liposome-inserting conjugate. 1. Gram-scale production and purification
DF Nellis et al.
BIOTECHNOLOGY PROGRESS (2005)
Maintenance of B cell anergy requires constant antigen receptor occupancy and signaling
SB Gauld et al.
NATURE IMMUNOLOGY (2005)
Normally occurring human anti-GM1 immunoglobulin M antibodies and the immune response to bacteria
ME Alaniz et al.
INFECTION AND IMMUNITY (2004)
High affinity as a disease determinant factor in anti-GM1 antibodies:: comparative characterization of experimentally induced vs. disease-associated antibodies
PHH Lopez et al.
JOURNAL OF NEUROIMMUNOLOGY (2002)
Anti-GM2 IgM antibody-induced complement-mediated cytotoxicity in patients with dysimmune neuropathies
B Cavanna et al.
JOURNAL OF NEUROIMMUNOLOGY (2001)
分享论文
